Go Pro

Brendan Smith Analyst Performance

Analyst at TD Cowen

Brendan Smith is a stock analyst at TD Cowen in the healthcare sector, covering 11 publicly traded companies. Over the past year, Brendan Smith has issued 20 stock ratings, including buy and hold recommendations. While full access to Brendan Smith's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brendan Smith's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
20 Last 0 Years
Buy Recommendations
55.00% 11 Buy Ratings
Companies Covered
11 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy55.0%11 ratings
Hold45.0%9 ratings
Sell0.0%0 ratings

Out of 20 total stock ratings issued by Brendan Smith at TD Cowen, the majority (55.0%) have been Buy recommendations, followed by 45.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
81.8% of companies on NASDAQ
9 companies
NYSE
18.2% of companies on NYSE
2 companies

Brendan Smith, an analyst at TD Cowen, currently covers 11 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
11 companies
100.0%

Brendan Smith of TD Cowen specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
6 companies
54.5%
BIOTECHNOLOGY
3 companies
27.3%
HEALTHCARE TECHNOLOGY
1 company
9.1%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
9.1%

Brendan Smith's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
8/7/2026Downgrade$8.57$9.00Hold
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
8/7/2026Boost Price Target$103.12$105.00Buy
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
8/3/2026Reiterated Rating$101.15Buy
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
7/22/2026Downgrade$31.15$31.00Hold
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
6/15/2026Boost Price Target$79.12$89.00Buy
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
6/15/2026Boost Price Target$76.17$89.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
4/21/2026Downgrade$6.16Hold
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
4/10/2026Lower Price Target$13.06$16.00Hold
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2/18/2026Reiterated Rating$73.19Buy
Azenta, Inc. stock logo
AZTA
Azenta
2/4/2026Reiterated Rating$28.54Hold
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
1/8/2026Boost Price Target$35.21$43.00Buy
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1/8/2026Boost Price Target$18.15$19.00Hold
Schrodinger, Inc. stock logo
SDGR
Schrodinger
1/8/2026Lower Price Target$18.58$24.00Buy
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
1/8/2026Boost Price Target$5.41$5.00Buy
Azenta, Inc. stock logo
AZTA
Azenta
1/8/2026Boost Price Target$37.27$39.00Hold
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
1/8/2026Boost Price Target$73.55$90.00Buy
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1/8/2026Lower Price Target$9.29$12.00Buy
Novavax, Inc. stock logo
NVAX
Novavax
11/4/2025Lower Price Target$7.64$7.00Hold
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10/29/2025Initiated Coverage$283.54$350.00Buy
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
9/30/2025Initiated Coverage$14.90$16.00Hold